These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 1329475

  • 21. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
    Karlberg BE, Fyhrquist F, Grönhagen-Riska C, Tikkanen I, Ohman KP.
    Scand J Urol Nephrol Suppl; 1984; 79():103-6. PubMed ID: 6089307
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Effect of angiotensin converting enzyme inhibitor lisinopril on sympathetic heart rate response during exercise in the early phase of acute myocardial infarction].
    Akashi Y, Tanabe K, Osada N, Samejima H, Seki A, Yokoyama Y, Nakayama M, Suzuki N, Oomiya K, Itoh H, Miyake F, Murayama M.
    J Cardiol; 2000 Oct; 36(4):221-9. PubMed ID: 11079227
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Determinants of the initial effects of captopril on blood pressure, glomerular filtration rate, and natriuresis in mild-to-moderate chronic congestive heart failure secondary to coronary artery disease.
    Motwani JG, Fenwick MK, Morton JJ, Struthers AD.
    Am J Cardiol; 1994 Jun 15; 73(16):1191-6. PubMed ID: 8203337
    [Abstract] [Full Text] [Related]

  • 28. Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension.
    Wallis EJ, Ramsay LE, Hettiarachchi J.
    Clin Pharmacol Ther; 1998 Oct 15; 64(4):439-49. PubMed ID: 9797801
    [Abstract] [Full Text] [Related]

  • 29. Effectiveness of preload reserve as a determinant of clinical status in patients with left ventricular systolic dysfunction. The SOLVD Investigators.
    Konstam MA, Kronenberg MW, Udelson JE, Kinan D, Metherall J, Dolan N, Edens T, Howe D, Kilcoyne L, Benedict C.
    Am J Cardiol; 1992 Jun 15; 69(19):1591-5. PubMed ID: 1598875
    [Abstract] [Full Text] [Related]

  • 30. Angiotensin-converting enzyme inhibition and physical training in heart failure.
    Meyer TE, Casadei B, Coats AJ, Davey PP, Adamopoulos S, Radaelli A, Conway J.
    J Intern Med; 1991 Nov 15; 230(5):407-13. PubMed ID: 1658183
    [Abstract] [Full Text] [Related]

  • 31. A study of the effects of lisinopril when used in addition to atenolol.
    Soininen K, Gerlin-Piira L, Suihkonen J, Kyllönen T, Parviainen R, Kyllönen E, Hämäläinen K, Lonka R, Tikkanen T, Selonen R.
    J Hum Hypertens; 1992 Aug 15; 6(4):321-4. PubMed ID: 1331443
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Sustained 24-hour blockade of the renin-angiotensin system: a high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor.
    Hasler C, Nussberger J, Maillard M, Forclaz A, Brunner HR, Burnier M.
    Clin Pharmacol Ther; 2005 Nov 15; 78(5):501-7. PubMed ID: 16321616
    [Abstract] [Full Text] [Related]

  • 35. Comparison of lisinopril versus placebo for congestive heart failure.
    Lewis GR.
    Am J Cardiol; 1989 Feb 21; 63(8):12D-16D. PubMed ID: 2537560
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Early neurohormonal effects of trandolapril in patients with left ventricular dysfunction and a recent acute myocardial infarction: a double-blind, randomized, placebo-controlled multicentre study.
    Sigurdsson A, Eriksson SV, Hall C, Kahan T, Swedberg K.
    Eur J Heart Fail; 2001 Jan 21; 3(1):69-78. PubMed ID: 11163738
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ.
    Clin Ther; 2008 Nov 21; 30(11):2030-9. PubMed ID: 19108791
    [Abstract] [Full Text] [Related]

  • 40. [Therapy with ACE inhibitors in chronic heart failure and limited kidney function].
    Osterziel KJ, Nagel F, Dietz R.
    Z Kardiol; 1994 Nov 21; 83 Suppl 4():81-7. PubMed ID: 7856286
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.